Albany, NewYork (PRWEB) October 17, 2013
LVADs are the mechanical devices which are implanted into the abdomen or chest and attached to a weakened heart to help it pump. LVADs are now sometimes used as an alternative to transplantation. LVAD is suitable for bridge-to-transplant market, which extends the patient’s life until a suitable donor is found, and for destination market, where patients suffer from heart failure but are not eligible for heart transplants, may be due to their age or some other illness that might get aggravated by heart transplantation.
Full report with TOC @ http://www.researchmoz.us/global-lvad-market-report-2013-edition-report.html.
Due to increasing demand for both BTT and DT, LVAD market is increasing tremendously. Also, with the rapid technological advancements in this segment, LVADs are expected to become a viable treatment option for heart failure patients in the future.
The report examines the LVAD market on a global scale and its various segments. The use of bridge-to-transplant has been more than destination therapy and is expected to rise in coming years. On the regional basis, the US accounts for the major share of the patients using LVAD due to improved outcomes and lower complication rates of the newer devices in comparison with international patients.
The major factors driving the LVAD market includes growing aging population, increasing diabetic population, reimbursement trends, expansion in the number of LVAD centers, rising healthcare expenditure and under-penetrated market. Also, growing bridge-to-transplant, which help patients to survive until a donor heart becomes available for transplant, is a major driver for LVAD market. But there are certain challenges which the industry is facing as of now which include barrier for DT adoption and safety issues.
Read all cardiovascular devices market research reports @ http://www.researchmoz.us/cardiovascular-devices-market-reports-61.html.
The competition in the global LVAD market is intense with few large players viz. Thoratec Corporation, Heartware International Inc. and Abiomed Inc.. The global competitive landscape along with the company profiles of the leading players in the market is discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Browse all Koncept Analytics market research reports @ http://www.researchmoz.us/publisher/koncept-analytics-24.html.
1. Heart Failure
1.2 Various Stages of Heart Failure
1.3 Available Treatment Options for HF
2. LVAD Market
2.1 Global LVAD Market
Market Value & Volume
Breakdown by Region
2.2 The US LVAD Market
Browse all latest market research report @ http://www.researchmoz.us/latest-report.html
List of Figures
Types of Heart Failure
Global LVAD Market (2008-2013E)
LVAD Pumps Sold Worldwide (2008-2013E)
Global LVAD Market – Value Share by Region (2013E)
The US Heart Transplant Donor Shortage (2006-2012)
Ageing Population Worldwide (2005-2013F)
LVAD Reimbursement Trend in the US (2006-2012)
Global Diabetic Population (2004-2012)
Post-Myocardial Infarction - Pipeline Review, H1 2013 (http://www.researchmoz.us/post-myocardial-infarction-pipeline-review-h1-2013-report.html)
Global Markets Directs, Post-Myocardial Infarction - Pipeline Review, H1 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Post-Myocardial Infarction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post-Myocardial Infarction.
Cardiovascular Device Companies (http://www.researchmoz.us/cardiovascular-device-companies-surveying-the-global-competitive-landscape-report.html)
This report provides an introduction focusing on the cardiac rhythm management (CRM) market and market leaders, Medtronic, Boston Scientific and St Jude Medical (SJM) and the difficult time they are facing in the CRM market. Selected key developments over the past year in the cardiovascular device industry are highlighted, focusing on key players including Sorin, Biotronik, Medtronic and Cordis. A look ahead considers how a new treatment for drug-resistant hypertension, renal denervation, is opening a new avenue in the market.
ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948